Cargando empresa
Just reported
Q3 2026 results
From Encompass Health's results release of 28 de octubre de 2026; its quarterly report has since been filed.
Revenue
Actual
1,61B US$
+8,9 % y/y
+0,8 % q/qGuided
—
No guide given
EPS, GAAP
Actual
1,50 US$
+21 % y/y
-2,6 % q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Encompass Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.22,8B US$A+
ENSGEnsign Group, Inc.10,9B US$A
PACSPACS Group, Inc.7,6B US$A
CONConcentra Group Holdings Parent, Inc.5,4B US$A
LFSTLifeStance Health Group, Inc.5,4B US$A
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct 2026CBGraded C, now B
MCKMckesson Corporation4 nov 2026BAGraded B, now A
CVSCVS Health Corp4 nov 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov 2026BAGraded B, now A
BIIBBiogen Inc.28 oct 2026BAGraded B, now A
Estados financieros completos →
Construido a partir de los propios informes de Encompass Health Corporation ante la Comisión de Bolsa y Valores de EE. UU. (SEC). Las cifras son las declaradas, con el historial por acción reexpresado a la base de acciones de hoy. Esto describe un negocio: no es asesoramiento de inversión ni una recomendación de compra o venta.
